Intravenous Immunoglobulin for Autoimmune Bullous Diseases: A Case Series from a Central European Referral Center

Background and Objectives: Autoimmune bullous diseases (AIBDs) may be treated with intravenous immunoglobulin (IVIG) infusions. This study aimed to evaluate the benefits and safety profiles of high-dose IVIG therapy in AIBD patients, as determined by clinical remission, the glucocorticosteroid-spari...

Descripción completa

Detalles Bibliográficos
Autores principales: Spałek, Maciej Marek, Bowszyc-Dmochowska, Monika, Dmochowski, Marian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10385677/
https://www.ncbi.nlm.nih.gov/pubmed/37512078
http://dx.doi.org/10.3390/medicina59071265

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10385677/
https://www.ncbi.nlm.nih.gov/pubmed/37512078
http://dx.doi.org/10.3390/medicina59071265

Ejemplares similares